Kestra Advisory Services’s Insmed INSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-1,307
Closed -$214K 3309
2026
Q1
$214K Sell
1,307
-1,224
-48% -$188K ﹤0.01% 2898
2025
Q4
$440K Sell
2,531
-262
-9% -$47.8K ﹤0.01% 2248
2025
Q3
$402K Buy
2,793
+128
+5% +$15.7K ﹤0.01% 2208
2025
Q2
$268K Sell
2,665
-27
-1% -$2.06K ﹤0.01% 2441
2025
Q1
$205K Buy
+2,692
New +$206K ﹤0.01% 2457

Other funds holding INSM

Kestra Advisory Services's INSM Position: Q2 2026 in Review

Kestra Advisory Services sold out of Insmed (INSM) in Q2 2026, closing a stake of 1,307 shares — an estimated $214K sold.

Kestra Advisory Services first reported a position in INSM in Q1 2025 and held it in 5 quarters. The position peaked at $440K in Q4 2025. 665 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

  • Kestra Advisory Services reported no remaining Insmed position as of Q2 2026 after selling out during the quarter.
  • Kestra Advisory Services sold 1,307 Insmed shares in Q2 2026, an estimated $214K.
  • Kestra Advisory Services first reported a position in Insmed in Q1 2025 and held it in 5 quarters.
  • Kestra Advisory Services's Insmed position peaked at $440K in Q4 2025.
  • 665 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on Kestra Advisory Services's 13F filing for Q2 2026, filed 28 Jul 2026.